Hepatic inflammatory myofibroblastic tumor: A case report.

Autor:	Tong M; Department of General Surgery, Jinzhou Medical University, Jinzhou 121001, Liaoning Province, China., Zhang BC; Department of General Surgery, Jinzhou Medical University, Jinzhou 121001, Liaoning Province, China., Jia FY; Graduate Management Office, Education and Teaching Department, Linyi People's Hospital, Linyi 276000, Shandong Province, China., Wang J; Department of Radiology, Linyi People's Hospital, Linyi 276000, Shandong Province, China., Liu JH; Department of Hepatobiliary Surgery and Minimally Invasive Institute of Digestive Surgery and Prof. Cai's Laboratory, Linyi People's Hospital, Linyi 276000, Shandong Province, China. jinghualiu1982@163.com.
Jazyk:	angličtina
Zdroj:	World journal of clinical cases [World J Clin Cases] 2023 Jun 26; Vol. 11 (18), pp. 4318-4325.
DOI:	10.12998/wjcc.v11.i18.4318
Abstrakt:	Background: Hepatic inflammatory myofibroblastic tumor (HIMT) is a rare type of hepatic tumor. It is always misdiagnosed and mistreated because it is primarily found with no obvious specific manifestation, and its imaging findings are diverse. Case Summary: Here, we report a case of HIMT that was initially diagnosed as liver malignancy but was confirmed as HIMT by histopathology after hepatectomy. Mostly, HIMTs are infiltrated with plasma cells and stain positively for anaplastic lymphoma kinase on immunohistochemistry as well as for some other kinases. Conclusion: HIMT can be treated with single nonsteroidal anti-inflammatory drugs and without surgery when it is diagnosed accurately. Because the etiology of HIMT is unknown and the diagnosis is difficult, the pathogenesis and clinical process need to be further studied. Competing Interests: Conflict-of-interest statement: The authors declare having no conflicts of interest. (©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu